Sentences with phrase «vaccine immunology»

Clinical and Vaccine Immunology 15 (10): 1547 - 1554.

«HIV has very few known sites of vulnerability, but in this work we've described a new one, and we expect it will be useful in developing a vaccine,» said Dennis R. Burton, professor in TSRI's Department of Immunology and Microbial Science and scientific director of the IAVI Neutralizing Antibody Center (NAC) and of the National Institutes of Health's Center for HIV / AIDS Vaccine Immunology and Immunogen Discovery (CHAVI - ID) on TSRI's La Jolla campus.

The Laboratory of Microbial Immunity is part of this Department, and its research focuses on host - pathogen interaction, recombinant vaccines and vaccine immunology.

The Laboratory of Molecular Microbiology and Biotechnology is part of this Department, and its research focuses on microbial genetics, host - pathogen interaction, recombinant vaccines and vaccine immunology.

Chief Operating Officer of the Duke Human Vaccine Institute (DHVI) and the Center for HIV / AIDS Vaccine Immunology (CHAVI) Professor of Medicine, Department of Medicine at Duke University Medical Center

They report their findings in the September 2013 issue of the journal Clinical and Vaccine Immunology.

Vaccine immunology is poorly understood in pregnancy and Tfh cell expansion has been shown to be a predictor of response to influenza vaccination outside of pregnancy.

Future work in this area will lead to a better understanding of vaccine immunology and how pregnant women respond to antigen exposure through the course of pregnancy.

Researchers led by a team at Duke University identified these immunologic variations by studying blood samples collected from people living with HIV by the NIAID - supported Center for HIV / AIDS Vaccine Immunology (CHAVI).

«We've shown that a specific type of these cells, known as follicular helper T (Tfh) cells are not only necessary, but are a limiting factor that differentiates between an average and a potent antibody response to HIV,» says Crotty, a scientific collaborator with the Center for HIV / AIDS Vaccine Immunology & Immunogen Discovery (CHAVI - ID), a major research consortium led by The Scripps Research Institute.

The team was led by Barton Haynes, M.D., director of the Duke Center for HIV / AIDS Vaccine Immunology - Immunogen Discovery (CHAVI - ID) and the Duke Human Vaccine Institute, and John Mascola, M.D., director of the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Voices For Vaccines Red Wine and Apple Sauce The Vaccine Times Virus Hunters Videos Vaccinate Your Family Shot at Life Nurses Who Vaccinate Moms Who Vaccinate Every Child By Two It's OK to Ask Family Vaccination Vaccine Immunology CHOP VEC Pinterest Page CHOP Pinterest Page CHOP YouTube Vaccine Series Immyounity

Not exact matches

Janssen Inc. is one of the Janssen Pharmaceutical Companies of Johnson & Johnson, which are dedicated to addressing and solving some of the most important unmet medical needs in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases.

I am switching from B.S. and M.S. in toxicology to a PhD in Microbiology and Immunology with a focus on malaria vaccine development research.

Jon Cohen News Writer (San Diego Bureau) Writes about AIDS, vaccines, immunology, and genome editing, including CRISPR.

He said that the most exciting arenas of immunology today include new strategies for vaccines and studies of regulatory T lymphocytes and the innate immune response, which is essentially the most general form of attacking pathogens.

With all of the interest in developing new therapeutics, new vaccines, and strategies for fighting bioterrorism, immunology poses many serious questions for scientists.

Opportunities exist for people with expertise including infectious diseases, epidemiology, molecular biology, immunology, and biostatistics,» says Eileen Barry, with the Center for Vaccine Development at the University of Maryland in Baltimore.

Notably, the basic skills needed for vaccine research are taught in most universities: immunology, molecular biology, protein purification and analysis, epidemiology, biostatistics, biochemical engineering.

New knowledge from the fields of immunology and microbiology has been applied to the development of vaccines in recent years.

«We think we can use our molecular, rational design approaches to make a better flu vaccine for people who really need it,» says study leader Andrew Pekosz, PhD, an associate professor in the Department of Molecular Microbiology and Immunology at the Bloomberg School of Public Health.

One of the hottest trends in immunology — injecting DNA as a vaccine — may actually have been invented millions of years ago.

In September, Roswell Park Cancer Institute in New York and Cuba's Center for Molecular Immunology announced that they would partner to test a cancer vaccine, said Cristina Rabadán - Diehl, director of the Office of the Americas in the Office of Global Affairs, Office of the Secretary at the U.S. Department of Health and Human Services.

While Ruth has focused on providing the basis for the development of a malaria vaccine, Victor concentrated on basic immunology, studying the structure and function of various immune components and the parasitology of malaria and Chagas disease.

It is significant protection that we observed and we have all the immunology to understand how the vaccine is working in the system.»

A major new finding that will significantly advance efforts to create the world's first antibody - based AIDS vaccine was published today by researchers from the La Jolla Institute for Allergy and Immunology.

A team of scientists at the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases, part of NIH, created VRC07 - αCD3 under the leadership of VRC Director John R. Mascola, M.D.; former VRC Director Gary J. Nabel, M.D., Ph.D.; and Richard A. Koup, M.D., VRC deputy director and chief of its immunology laboratory.

«With more than 1.7 million people dying globally from TB each year and the rise of strains that are resistant to drug treatment, we need a better way to prevent this disease,» said the study's principal investigator Louis Picker, M.D., who is the associate director of the OHSU Vaccine and Gene Therapy Institute and a professor of pathology, molecular microbiology, and immunology in the OHSU School of Medicine.

«There is a need to understand what's happening with the existing live vaccine and potentially a need to develop a new one,» said David Topham, Ph.D., Marie Curran Wilson and Joseph Chamberlain Wilson Professor of Microbiology and Immunology at URMC and author of the study.

«This study has changed our approach to developing a universal flu vaccine,» said corresponding author Maureen McGargill, Ph.D., an assistant member of the St. Jude Department of Immunology.

«We learned in this study that grabbing hold of these glycans can be a very important early step in an effective immune response to HIV, and with this knowledge, we believe we can design better candidate vaccines,» said principal investigator Dennis R. Burton, professor of immunology and microbiology at TSRI.

That's the question posed by researchers in the journal BMC Immunology, who think that the vaccine might have offered partial protection against HIV.

Even if the vaccine works only in Latin America, it will still be a «significant improvement over what we have now», says Howard Engers, head of malaria immunology at the WHO.

«This basically changes our whole view of the pathogenesis of HIV infection,» says Daniel Douek, chief of the Human Immunology Section at the National Institutes of Health's Vaccine Research Center.

The finding is exciting «because it suggests that the seasonal flu vaccine boosts antibody responses and may provide some measure of protection against a new pandemic strain that could emerge from the avian population,» said senior study author Paul G. Thomas, PhD, an Associate Member in the Department of Immunology at St. Jude.

If these genes were highly active before vaccination, an individual would generate a high level of antibodies after vaccination, no matter the flu strain in the vaccine, researchers report online August 25 in Science Immunology.

«The optimal strategy for protecting people and animals against this deadly disease would be through vaccination, but there are no FDA - licensed plague vaccines available in the U.S.,» said Ashok Chopra, UTMB professor of microbiology and immunology.

In their report published in Cancer Immunology Research, a team from the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital (MGH) describes how adding AMD3100 (plerixafor)-- previously approved for the stimulation of stem cell production prior to bone marrow transplantation — to their investigational drug VIC - 008 more than doubled the animals» survival time.

Assistant Research Professor Institute for Immunology and Informatics Director Vaccine Research, EpiVax, Inc. 401-277-5245 [email protected]

Anti-flu peptides could become handy when vaccines are unavailable, in the case of a new pandemic strain, or when circulating strains become resistant to current drugs, says senior author Joshy Jacob, PhD, associate professor of microbiology and immunology at Emory Vaccine Center and Emory University School of Medicine.

Only one vaccine has been licensed, and neither it nor any others in development today will be 100 percent effective against malaria infection, said lead researcher José A. Stoute, associate professor of medicine and microbiology and immunology.

Peter Andersen, Vice-president and head of Vaccine R&D: Adjunct Professor of Immunology from the University of Copenhagen who has published more than 270 papers and 20 patents.

«We've optimized a vaccine against heroin,» said Kim Janda, a professor in the chemistry and immunology department at The Scripps Research Institute (TSRI) and a senior member of the research team.

IRTA offers expertise and facilities to internal and external clients (academic and industry) for fundamental and applied research on bacterial and viral vaccines, including expertise on pigs, poultry and ruminants in the fields of epidemiology, microbiology, virology, immunology, pathology, molecular biology, and entomology.

UNC School of Medicine researchers Aravinda de Silva, PhD, professor of microbiology and immunology, and Stefan Metz, PhD, are creating a nanoparticle vaccine that in experiments showed increased antibody responses against one serotype of dengue virus.

Partnering with The Wistar Institute is one of the soundest investments you can make to advance biomedical research and potentially groundbreaking discoveries in cancer, vaccines and immunology.

A feasibility study: association between gut microbiota enterotype and antibody response to seasonal trivalent influenza vaccine in adults — Nick Shortt — Clinical and Translational Immunology

William Schief is a Professor in the Immunology and Microbial Science Department at The Scripps Research Institute in La Jolla, CA, Director for Vaccine Design at the International AIDS Vaccine Initiative (IAVI), and an Associate Member of the Ragon Institute of MGH, MIT and Harvard.

Rama Rao Amara, a vaccine researcher at Emory Vaccine Center and Yerkes National Primate Research Center, and Harriet Robinson, former head of microbiology and immunology at Yerkes and now chief scientific officer at the firm GeoVax, both described extra ingredients for the DNA / MVA vaccine that Robinson designed while at Yerkes in collaboration with NIH reseavaccine researcher at Emory Vaccine Center and Yerkes National Primate Research Center, and Harriet Robinson, former head of microbiology and immunology at Yerkes and now chief scientific officer at the firm GeoVax, both described extra ingredients for the DNA / MVA vaccine that Robinson designed while at Yerkes in collaboration with NIH reseaVaccine Center and Yerkes National Primate Research Center, and Harriet Robinson, former head of microbiology and immunology at Yerkes and now chief scientific officer at the firm GeoVax, both described extra ingredients for the DNA / MVA vaccine that Robinson designed while at Yerkes in collaboration with NIH reseavaccine that Robinson designed while at Yerkes in collaboration with NIH researchers.

Wistar is poised for the future to make major research advances in the areas of cancer, immunology and vaccines, but we need your support.